Immune Checkpoint Inhibitors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Immune Checkpoint Inhibitors
May 17, 2024, 17:53 |
Insight
Piotr Wysocki: Better responses to immunotherapy in NSCLC patients with rare EGFR mutation
Piotr Wysocki recently posted on LinkedIn: "The efficacy of immune checkpoint inhibitors (ICI) as monotherapy in…
May 14, 2024, 08:56 |
Insight
UCLA: Adding immune-boosting agent to personalized cancer vaccine supercharges the body's immune defense against malignant brain tumors
The combination of poly-ICLC with an immunotherapy vaccine utilizing dendritic cells is a promising approach…
May 12, 2024, 13:30 |
Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
May 12, 2024, 07:25 |
Blog
Stephen Liu: Dr. Solange Peters at Rome Lung 24 with a dynamic discussion of next-generation ICIS
Stephen Liu shared on X: "Dr. Solange Peters at Rome Lung 24 with a dynamic…
May 5, 2024, 13:13 |
Blog
Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation! - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "STAFF SPOTLIGHT: Congratulations to Dr. Tim Greten, the…
Apr 28, 2024, 12:38 |
Insight
Piotr Wysocki: Combined treatment (TKI+ICI) does not benefit favorable-risk mRCC patients
Piotr Wysocki recently shared on LinkedIn: "For several years, combined therapy based on the administration of…
Apr 28, 2024, 01:22 |
Blog
Patrick Hwu: Always great to catch up with our incredible founder Lee Moffitt
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared on X: “Always great to catch…
Apr 26, 2024, 07:37 |
Blog
Meet the Author Amin H. Nassar by Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared on X/Twitter: "Meet the Author: Amin H. Nassar, a medical…
Apr 16, 2024, 12:58 |
Drugs
Emre Yekedüz: A retrospective study from Gustave Roussy
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…
Apr 14, 2024, 10:26 |
Insight
Iván González: A comprehensive review of immune system adverse events due to cancer immunotherapy
Iván González, Medical Oncologist at Comprehensive Oncology Center of the Hospital Ángeles Puebla, shared on…
1
2
All:
19
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube